Smart Drug Development & Design from Candidate to Phase I

Smart Drug Development & Design from Candidate to Phase I

This event, which is hosted by Catalent and BioRN, will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.

For more information, please see the program in the download area on the right or click here!

The event is free of charge, but registration is required.

Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (az@biorn.org).

 

Date 

  • 4 Apr 2019

Time 

  • 09:30 - 14:15 Uhr

Location 

Conference Center Technology Park, Heidelberg